Learn more

JEIL PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    46
  • GoodIP Patent Rank
    49,892
  • Filing trend
    ⇩ 89.0%
About

JEIL PHARMACEUTICAL CO LTD has a total of 46 patent applications. It decreased the IP activity by 89.0%. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), Republic of Korea and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and consumer goods are HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH, HELMHOLTZ ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH and CHEN JIANXIN.

Patent filings per year

Chart showing JEIL PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Joseph 13
#2 Park Chun-Ho 11
#3 Ye In-Hae 10
#4 Chun Kwangwoo 10
#5 Kim Jeongmin 9
#6 Lee Hyunho 8
#7 Kim Myung-Hwa 8
#8 Park Yoonsun 8
#9 Jang Eunsung 8
#10 Cho Myung Soo 6

Latest patents

Publication Filing date Title
KR20210014024A Method of treating stroke using tricyclic derivatives
WO2021020612A1 Method for treating stroke by using tricyclic derivative
KR20190124071A Pharmaceutical formulation
KR20190060235A Preparation Method Camphorsulfonic acid Salt of Sitagliptin
KR20190057569A 7-amino-1H-indole-5-carboxamide derivatives, and use thereof
WO2018048209A1 Apparatus for ultrathin-cutting cell colonies or tissues and a fragmenting method using the same
KR101783977B1 Preparing methods for pluripotent stem cell derived-neuronal progenitor cell inhibiting formation of teratoma
KR101777971B1 Imidazo[1,2-a]pyridine derivatives, methods of preparing the same and use thereof
KR20160095342A Pharmaceutical composition comprising ecabet or pharmaceutically acceptable salts thereof as an active ingredient
WO2012150829A2 Noble triazolopyridine derivative or pharmaceutically acceptable salts thereof, production method thereof, and pharmaceutical composition including same
WO2013111918A1 Composition comprising extracts of angelica gigas and wild garlic as active ingredients for preventing or treating diabetes or complications from diabetes
WO2012047063A2 Pharmaceutical composition for aiding dementia treatment or treating dementia, containing angelica gigas nakai extract only, ginkgo leaf extract only, or mixture of angelica gigas nakai extract and ginkgo leaf extract
WO2012021014A2 Composition for preventing or treating diabetes or diabetes complications, containing composite composition of angelicae gigantis radix extract and wild garlic leaves extract as active ingredient
WO2007008037A1 Novel chromen-2-one based hydroxamic acid derivatives having anti-inflammatory activity, the preparation thereof and a composition containing the same for treating inflammatory disease